Skip to main content
. 2017 Nov 13;13(52):634–638. doi: 10.4103/pm.pm_546_16

Figure 2.

Figure 2

Ligustilide inhibited the increased activation of spinal c-Jun N-terminal kinase caused by CFA. (a) Western blotting showed that CFA injection caused an upregulation of p-c-Jun N-terminal kinase/p-c-Jun in the spinal cord and administration of ligustilide blocked the increased expression of spinal p-c-Jun N-terminal kinase/p-c-Jun induced by CFA. (b and c) The fold change for the density of p-c-Jun N-terminal kinase level normalized to c-Jun N-terminal kinase; and the density of p-c-Jun normalized to glyceraldehyde-3 phosphate dehydrogenase, as shown in Figure 2a. Data were all expressed as mean ± standard deviation ###P < 0.001, compared with “Control + Vehicle” group. **P < 0.01, ***P < 0.001, compared with “CFA + Vehicle” group. CFA: Complete Freund's adjuvant